Evidence for functional β-adrenoceptor subtypes in CG-5 breast cancer cells

Pharmacological Research

Volumn 33, Issue 4-5, 1996, Pages 255-260

  Re, G ^a   Badino, P ^a   Novelli, A ^a   Girardi, C ^a   Di Carlo, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast cancer; cAMP; CG 5 cells; adrenoceptors

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; DOBUTAMINE; ISOPRENALINE; NORADRENALIN; PROPRANOLOL;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOMETRY; SCATCHARD PLOT;

EID: 0030130471     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0036     Document Type: Article

References (36)

1. 1. Lefkowitz RJ, Hoffman BB, Taylor P. Neurohumoral transmission: the autonomic and somatic motor nervous systems. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press, 1990: 84-121.
2. 2. Marchetti B, Spinola PG, Pelletier G, Labrie F. A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of β-adrenergic receptors and correlation with tumor growth. J Steroid Biochem Mol Biol 1991; 38: 307-20.
3. 3. Marchetti B, Fortier M, Poyet P, Follea N, Pelletier G, Labrie F. Adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. Endocrinology 1990; 126: 565-74.
4. 4. Wellner RB, He X, Marmary Y, Baum B. Functional β-adrenergic receptors in a human mammary cell line (HBL-100). Biochem Pharmacol 1988; 37: 3035-7.
5. 5. Vandewalle B, Revillion F, Lefebvre J. Functional β-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol 1990; 116: 303-6.
6. 6. Perry JW, Oka T. Cyclic AMP as a negative regulator of hormonally induced lactogenesis in mouse mammary gland organ culture. Proc Natl Acad Sci USA 1980; 77: 2093-7.
7. 7. Plucinski TM, Baldwin RL. Effects of hormone on mammary adenosine 3′-5′-monophosphate levels and metabolism in normal and adrenolectomized lactating rats. Endocrinology 1982; 111: 2062-5.
8. 8. Yang S, Guzman R, Richards S, Imagawa W, McCormick K, Nandi S. Growth factor and cyclic nucleotide induced proliferation of normal and malignant mammary epithelial cells. Endocrinology 1980; 107: 35-41.
9. 9. Klein DM, Loizzi RF. Enhancement of R3230 AC rat mammary tumor growth and cellular differentiation by dibutyrylic cAMP. J Natl Cancer Inst 1988; 158: 813-8.
10. 10. Pastan I, Johnson GS, Anderson WB. Role of cyclic nucleotides in growth control. Annu Rev Biochem 1975; 44: 491-523.
11. 11. Pack TT. Studies on cell transformation. Somatic Cell Genet 1989; 5: 973-90.
12. 12. Yabushita H, Sartorelli AC. Effects of sodium butyrate, dimethylsulphoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2. Oncol Res 1993; 5: 173-82.
13. 13. Draoui A, Vandewalle B, Hornez L, Revillion F, Lefebvre J. β-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors. Anticancer Res 1991; 11: 677-80.
14. 14. Re G, Badino P, Girardi C, Di Carlo F. Effects of a β2-agonist clenbuterol on cultured human (CG-5) breast cancer cells. Pharmacol Res 1992; 26: 377-84.
15. 15. Natoli C, Sica G, Natoli V, Serra A, Iacobelli S. Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat 1983; 3: 23-32.
16. 16. Iacobelli S, Sica G, Natoli C, Gatti D. Inhibitory effects of medroxyprogesterone acetate on the proliferation of human breast cancer cells. In: Campio L, Robustelli della Cuna G, Taylor RW, eds. Role of medroxyprogesterone in endocrine-related tumors, Vol. II. New York: Raven Press, 1983: 1-6.
17. 17. Sica G, Natoli C, Marchetti P, Piperno S, Iacobelli S. Tamoxifen induced membrane alterations in human breast cancer cells. J Steroid Biochem 1984; 20: 425-8.
18. 18. Iacobelli S, Natoli C, Natoli V, Sica G, Gaggini C. Effects of the antiestrogen, tamoxifen, on protein synthesis and cell division of human breast cancer cells in vitro. In: Iacobelli S, Lippman ME, Robustelli della Cuna G, eds. The role of tamoxifen in breast cancer. New York: Raven Press, 1982: 1-8.
19. 19. Ortmann O, Sturm R, Knuppen R, Emons G. Weak estrogenic activity of phenol red in the pituitary gonadotroph: re-evaluation of estrogen and antiestrogen effects. J Steroid Biochem 1990; 35: 17-22.
20. 20. Freshney RI. Culture of animal cells. A manual of basic technique, 2nd edn. New York: Wiley-Liss, 1987: 245-56.
21. 21. Re G, Badino P, Novelli A, Girardi C. Identification of β-adrenoceptor subtypes in bovine ovarian and myometrical cell membranes. Br Vet J 1995; 151: 567-78.
22. 22. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
23. 125I)iodocyanopindolol? J Recept Res 1992; 12: 369-87.
24. 24. Law MP. Demonstration of the suitability of CGP-12177 for in vivo studies of β-adrenoceptors. Br J Pharmacol 1993; 109: 1101-9.
25. 2-adrenergic receptor gene in pregnant rat myometrium. J Biol Chem 1992; 267: 7975-8.
26. 26. Lemoine H. β-adrenoceptor ligands: characterization and quantification of drug effects. Quant Struct - Act Relat 1992; 11: 211-8.
27. 27. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-9.
28. 28. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs, 2nd edn. New York: Springer-Verlag; 1987: 110-28.
29. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-108.
30. 30. Green H. Cyclic AMP in relation to proliferation of the epidermal cells: anew view. Cell 1978; 15: 801-11.
31. 31. Kung WM, Handloser K, Eppenberger U. Cyclic AMP-dependent protein kinases and cAMP-binding proteins in human mammary tumor MCF-7 cells. Arch Gynecol 1984; 234: 173-9.
32. 32. Cho-Chung YS, Clair T, Badwin JS, Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyril cyclic AMP and L-arginine. Science 1981; 214: 77-9.
33. 33. Novelli A, Badino P, Re G. Competizione in vitro del clenbuterolo per i recettori per gli estrogeni e per il progesterone nell'utero di ratio. Atti Soc Ital Sci Vet 1992; 46: 1315-19.
34. 34. DiGiovanni L, Austin R, Phillippe M. Steroid hormone modulation of cAMP in response to β-adrenergic receptor stimulation in genetal tract myocytes. In Vitro Cell Dev Biol 1992; 28A: 509-14.
35. 35. Re G, Badino P, Dacasto M, Di Carlo F, Girardi C. Regulation of uterine estrogen receptors (ER) by β-adrenergic stimulation in immature rats. J Vet Pharmacol Ther 1993; 16: 328-34.
36. 2-adrenergic receptors by progesterone and estradiol-17β in late pregnant rats. Biol Reprod 1991; 40: 531-40.